Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
admin Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read Moredrug
Medical cannabis maker Cantourage surges in Frankfurt debut
Medical cannabis maker Cantourage soared in its debut in Frankfurt on Friday. With the ticker…
Read MoreAurora Cannabis reports bigger loss than expected, but execs stick with profit target
Aurora Cannabis Inc. on Thursday reported a bigger quarterly loss and lower sales than expected,…
Read MoreJuul secures financing to avoid bankruptcy and plans to cut 30% of jobs globally
Juul Labs Inc. has secured a cash infusion from some of its early investors to…
Read MoreWana Brands CEO makes seven-figure donation to fund cannabis research
Wana Brands founder and CEO Nancy Whiteman is stepping up her charitable activities with $3…
Read MoreVoters approve cannabis use for adults in one red state, one blue state
Industry pundits mostly praised the mixed results for cannabis votes in Tuesday’s midterm elections, as…
Read MoreMaryland may become 20th state to OK cannabis for adults
Voters in Arkansas, Maryland, Missouri, North Dakota and South Dakota are weighing in on legal…
Read MoreCuraleaf earnings show legal U.S. weed sales flattening out as prices decline
U.S. cannabis producer Curaleaf Holdings Inc. on Monday reported a bigger loss than expected during…
Read MoreAmid steep inflation, one thing is getting cheaper: cannabis
U.S. consumers continue to face the highest prices in decades for gasoline and other products,…
Read MoreAmid steep inflation, one thing is getting cheaper: cannabis
U.S. consumers continue to face the highest prices in decades for gasoline and other products,…
Read More